Lymphadenitis as a Rare Side Effect of H1N1 Vaccine in a Child by Gundogdu, Zuhal & Seyhogullari, Mualla
Hindawi Publishing Corporation
Case Reports in Medicine
Volume 2010, Article ID 459543, 3 pages
doi:10.1155/2010/459543
Case Report
Lymphadenitisas a Rare Side Effectof H1N1 Vaccine in a Child
ZuhalGundogduandMuallaSeyhogullari
Kocaeli Medical Centre, 41100 Kocaeli, Turkey
Correspondence should be addressed to Zuhal Gundogdu, z.gundo@gmail.com
Received 23 August 2010; Accepted 5 November 2010
Academic Editor: Robert S. Dawe
Copyright © 2010 Z. Gundogdu and M. Seyhogullari. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
We present a 5-year-old boy who had the complaint of swelling and pain on the right vaccine shot and right axillary areas.
The right axillary area was diagnosed as reactive lymphadenitis, which we believe is a rare local side eﬀect of the swine ﬂu vaccine.
The key message to take away from this case is that the patient had lymphadenitis as a local side eﬀect of the swine ﬂu vaccine.
Lymphadenitis should be reported as a possible local side eﬀect of the swine ﬂu vaccine.
1.Introduction
2009 H1N1 inﬂuenza also called Swine Flu, is caused by a
new strain of the inﬂuenza virus, and it has spread through
manycountries.Vaccinesareavailabletoprotectagainst2009
H1N1 inﬂuenza a vaccine, like any medicine, could cause
serious problems such as a severe allergic reaction. However,
the risk of any vaccine causing serious harm, or death, is
extremely small [1].
Approximately 44% of people who were administered
swine ﬂu vaccine reported mild side eﬀects within 7 days
of receiving the ﬁrst dose of swine ﬂu vaccine of CSL
Biotherapies. 2.5% of the vaccine recipients reported yet
moderate local side eﬀects, and there were no severe adverse
events reported following immunization [2].
Lymphadenitis is the inﬂammation and/or enlargement
of a lymph node. The most common symptoms of lym-
phadenitis are swelling of one or more lymph nodes which
mayfeelslightlyhardenedandmaybepainfulwhentouched.
2 .T h eC as eS t ud y
On December 9, 2009, a previously healthy 5-year-old boy
with no history of illness was brought into the paediatrics
clinic with complaints of pain in the upper part of the right
arm (vaccine shot area), accompanied by swelling, bruising,
and pain in the right axillary without any sign of fever.
His past medical history, family history, and social history
are unremarkable.
He had swine ﬂu vaccine administered intramuscularly
in a local health authority clinic on the 8th of December
2009. Novartis H1N1 vaccine was administered to the child
withasignedparentalconsentformrequestedbytheTurkish
Ministry of Health. Parents of the boy realised a swelling
in the right arm where the vaccine was administered as
well as a swelling in the right axillary area on the night of
the same day when the boy started to complain about a
pain. When he was brought into the paediatrics clinic on
December 9, 2009, a day after the vaccination, examination
revealed a hard and painful mass of nearly 2cm in diameter
on the right upper arm shot area with two other painful but
small right axillary swellings. The examination of the other
systems revealed no pathology. For the diﬀerential diagnosis,
axillary ultrasonography (USG) examination was requested
alongside tests forblood count (CBC) and C-reactive protein
(CRP). Laboratory investigations of CBC and CRP were
normal. The patient was not given any anti-inﬂammatory,
antiallergic or antibiotic treatments.
The boy was called into the clinic three days later on
the 12th of December 2009 for a physical examination;
it was found that swelling of the vaccine shot area still
existed although the pain had decreased. The parents turned
down our request to take a biopsy for histopathological
examination.2 Case Reports in Medicine
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Figure 1: USG scans of the right axillary area taken one day after the vaccination on the 9th of December 2009.
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Figure 2: USG scans of the right axillary area taken 2 weeks after the vaccination on the 22nd of December 2009.
Ultrasound is a useful imaging modality in assessment of
lymph nodes, and its features can help only in identifying
abnormal nodes including size, shape, echogenic hilus,
hypoechogenicity or isoechogenicity, echogeneity, coagula-
tion necrosis, and a sharp nodal border [3].
Ultrasound features can help identify whether lym-
phadenitis is reactive or not. In this case, three USG results
showed that this is a postvaccine lymphadenitis because
of long-to-short-axis ratio (L/S ratio), oval shape, and
hyperechoic hilum.
A right axillary USG showed a reactive lymph nodule in
the superior area with a size of 15 × 8mm(Figure 1(a))a n d
two in the inferior area with dimensions of 9 × 6mmand
7 × 6mm(Figure 1(b)). They were of fuzzy form shape with
hypoechogenic cortex with clear echogenic hilus indicator.
In the Doppler mode, only hilus vascular structures were
observed. These ﬁndings are meaningful for acute reactive
lymphadenitis. Fuzzy form and echogenic hilus indicate a
benign lymphadenitis as hypoechogenic cortex is usually
observed in acute cases.
The boy had been called into the outpatients’ clinic a
week later on the 16th of December 2009 when a second
USG taken did reveal that 7 × 6mm nodule had disappeared
and there were no signiﬁcant changes in the structure and
size of the other two nodules. Bruising had completely
disappeared. However, the third USG scan carried out
two weeks later on the 22nd of December 2009 revealed
a decrease in nodule dimensions from 15 × 8mm to
12 × 6mm (Figure 2(a)) and the second nodule changed
from 9 × 6t o1 0× 4mm as shown in Figure 2(b).
Furthermore, a decrease in the cortex echo and increased
hilus echogeneity were also observed indicating reactive
acute lymphadenitis. The physical examination carried out
on the ﬁfteenth day revealed that the patient’s arm was back
to normal.
3. Discussion
86% of the volunteers who received Novartis’s H1N1 (7.5µg
of MF59 adjuvanted) vaccine reported adverse reactions
after one or both doses—the most common local side eﬀect
experienced was a pain in the injection site. The reactions
were generally mild or moderate and resolved themselves
after 72 hours [4]. The majority of reported local adverse
events, or side eﬀects occurring at the location where either
vaccine had been administered, include tenderness pain,
redness, hardening of skin, swelling, and bruising [2, 4]. The
boy presented in this report started complaining about pain
and swelling on the night of the same day he had received
H1N1 vaccination.Case Reports in Medicine 3
Systemic eﬀects were also reported by CSL Biotherapies
and Novartis vaccine recipients. Approximately 36% of
volunteers who received the swine ﬂu vaccine manufactured
by CSL experienced mild systemic side eﬀects. 8% of the
vaccine recipients reported moderate systemic side eﬀects,
and less than 1% experienced a severe adverse reaction to
immunization. Severe side eﬀects reported include malaise,
muscle pain, and nausea. Muscle aches were the most com-
mon systemic side eﬀect reported by participants receiving
the H1N1 vaccine produced by Novartis, and no severe
systemic side eﬀects were reported. The following are
common whole-body side eﬀects occurring in response to
either H1N1 vaccination: headache, malaise, muscle pain,
chills, nausea, fever, and vomiting. In addition, researchers
evaluatedtheoccurrenceofselectneurologicaladverseevents
[2, 4].
When a lymph node rapidly increases in size, its capsule
stretches and causes pain. Pain is usually the result of
an inﬂammatory process [3]. Most inﬂammatory diseases
involve lymph nodes diﬀusely and homogeneously, generally
preserving their oval shape. If threshold value of the long-
to-short-axis ratio (L/S ratio) employed is low, then the
accuracy of US in diﬀerentiating normal/reactive node
(oval shape) from pathogic nodes (rounded shape) is also
relatively low (sensitivity 71%, speciﬁty 65%) [5]. If the ratio
used is 2.0, sensitivity increases to 81–95% and speciﬁty
to 67–96%. The second parameter to be assessed is the
hyper echoic central line of lymph nodes (the hilum). The
sonographic detection of the hyper echoic hilum has always
beenrelatedtotheprobablebenignnatureofthelymphnode
[5].
Postvaccinal lymphadenitis is a reactive response of the
lymph node to the vaccination. Some of the vaccines such as
BCG, varicella zoster, and pneoumococcal can cause reactive
lymphadenitis, and it is a rather common complication of
BCG vaccination [6, 7]. Local reactions (generally erythema
and induration with or without tenderness) are common
after the administration of vaccines containing diphtheria,
tetanus, or pertussis antigens. Occasionally, a nodule may be
palpable at the injection site of adsorbed products for several
weeks [8].
We followed this patient for nearly twenty days but we
did not encounter any systemic reaction. This was not a
suppurative lymphadenitis characterized by appearance of
ﬂuctuation with erythema and edema of the overlying skin.
The size of lymphadenitis has decreased and disappeared
completely after 15 days.
We are of the opinion that further study is required
f o rt h i st y p eo fs i d ee ﬀect and a detailed histopathological
examination could be of use. The parents turned down our
request to take a biopsy for histopathological examination.
However, our results have been conclusive enough that this
case was a reactive lymphadenitis.
In a conclusion, reactive lymphadenitis is an unusual
side eﬀect of swine ﬂu vaccination requiring further study,
and to the best of our knowledge no cases in children
have previously been reported in the literature neither by
CDC nor by WHO sources, apart from a case reported in
an adult [9].
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